HIV: Nigeria, Africa Bound to Innovate Despite US Aid Freeze Waiver

HIV: Nigeria, Africa Bound to Innovate Despite US Aid Freeze Waiver

  • The United States President’s Emergency Plan for AIDS Relief (PEPFAR) has disbursed over $7.8 billion to ensure all Nigerians living with HIV/AIDS have comprehensive access to quality HIV prevention, care, and treatment services
  • The 47th president of the United States, Donald Trump, initially decided to cut funds to support HIV in developing countries
  • As the new administration in the United States reviews the PEPFAR-powered-generosity, Nigerian authorities can embrace innovation

Legit.ng journalist Ridwan Adeola Yusuf has over 9 years of experience covering health matters and global affairs.

FCT, Abuja - Disappointment, dejection, and despair: those were the feelings long-term HIV patient Hassan Hawau (she chose this pseudonym due to stigmatisation concerns) felt when news of the Donald Trump administration halting HIV drug distribution in less-developed nations surfaced.

HIV (human immunodeficiency virus) is a disease that attacks the body’s immune system. If not appropriately treated, it can lead to acquired immunodeficiency syndrome (AIDS), an ailment that used to be the fourth biggest killer worldwide.

Read also

Prominent governorship candidate joins APC 2 months after dumping Peter Obi’s Labour Party

HIV: Nigeria and Africa need to react strongly despite US aid freeze waiver
The chaos of Donald Trump's foreign aid freeze implies that now is the time for Nigeria and Africa to take their health systems seriously. Photo credits: USAIDAfrica, @realDonaldTrump
Source: Twitter
“I found out in August of 2010 that I had HIV, and the reason for testing was because my partner at the time had heard gossips that I dated someone who was [HIV] positive,” Hawau recalled with a sigh while speaking with Legit.ng. “Hitherto, HIV was sort of a taboo. I came from a suburb area in Niger state, so the disease was typically not for me.”

Hawau was 20 when she discovered it; it took her a very long time to finally accept her status. Now a wife and mother to two healthy children, Hawau is on HIV antiretroviral (ARV) therapy in Nigeria, an effort supported by the United States government. More than 1 million people living with HIV (PLHIV) in Nigeria are on antiretroviral therapy (ART) as of March 2023.

Millions of people are on antiretroviral therapy (ART) in Africa
A man takes his antiretroviral drugs (ARVs) pills. Photo credit: /SOPA Images
Source: Getty Images

ART drugs are expensive, hence the partnership between the Nigerian government and the US President's Emergency Plan for AIDS Relief (PEPFAR) funding. The alliance ensures that people living with HIV are surviving.

Read also

Did US authorities find $5 billion in 'Buhari’s New York house'? Fact emerges

There are about 1.9 million people with HIV in Nigeria, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the National Agency for the Control of AIDS (NACA). Coverage of HIV treatment in the country in 2021 was around 90%, up from 50% in 2015—thanks to the partnership.

For Gabriel Adedotun (he requested confidentiality), he was not sick. He just tested out of curiosity but was shocked to have his result return positive.

Adedotun, 21, takes PEPFAR-supplied antiretroviral pills daily and it is working.

“Within two months of beginning this medicine, my viral load became inconspicuous,” he told Legit.ng with a bright smile.
Microsoft Copilot
Adedotun eats well and exercises often, and apart from an issue with his cholesterol level (a common side effect of HIV medication), he is in fine health. Photo illustration: Microsoft Copilot
Source: UGC

PEPFAR's success in curbing HIV

Before the introduction of ARVs, developing countries lost a lot of people, registered so many orphans, and had babies born with HIV. However, collaboration ensured that many lives were saved. With treatment, people can stay 20 years with HIV and still be strong and healthy. They can have HIV-negative babies and relish a normal relationship.

Read also

Could the US really be sending $50 million worth of condoms to Gaza, as Trump claims?

PEPFAR countries
PEPFAR saves lives, prevents millions of HIV infections, and supports several countries to achieve HIV epidemic control—all while significantly strengthening global security. Photo credit: @domynych
Source: Twitter

PEPFAR is deemed one of the most remarkable interventions in history. The initiative had some impacts on the HIV pandemic in the 12 focus countries in sub-Saharan Africa through increasing humanitarian funding, providing access to cost-effective ARV medication, developing improved healthcare infrastructures, and implementing a number of prevention programmes.

Across Nigeria and 54 other countries around the world, PEPFAR is providing lifesaving HIV treatment for 20.6 million people, including 566,000 children.

Although the US has been involved in efforts to address the global AIDS crisis since the mid-1980s, the creation of PEPFAR in 2003 marked a significant increase in funding and attention to the epidemic. Thus, when the new government of Trump released a memo on Friday, January 24, 2025, that paused all foreign assistance, the update sent a wave of surprise and confusion in parts of the globe.

The freeze turned out to be abrupt, but its ensuing confusion reigns.

Read also

Trump reverses executive order on ban of emergency HIV treatment funding to poor countries

An “emergency humanitarian waiver” to support US-funded HIV treatment in 55 countries, including Nigeria, was approved on Wednesday, January 29, 2025. The joint United Nations programme on HIV/AIDS in a statement noted that the US government approved the waiver to allow people living with HIV to continue accessing treatment.

The waiver is welcome news for individuals like Hawau and Adedotun whose ARV supplies were threatened by the US directive. A withdrawal of the USA funding would have meant they stand to suffer. PEPFAR Nigeria remains the biggest donor for treatment programmes in the country, as their contributions cover approximately 90% of the treatment burden.

Deep concern despite US aid waiver

Due to the fact that not all humanitarian assistance has been cleared by the Trump administration (as of the time of this report), it remains unclear how exceptions by the current government will affect organisations working with outpatients, refugees, asylum seekers, and migrants.

Read also

Donald Trump: HIV positive lady breaks silence after US government halts free ARVs for poor countries

The situation is causing worry for non-governmental organisations (NGOs) across Africa, the Middle East, Ukraine, and Southeast Asia, which began shutting doors, sending staff home and turning away their dependents.

Officials from the US Agency for International Development (USAID), aid groups, and health workers revealed that they were not sure what the waiver meant for their work or if it was a full reversal of previous orders.

Elizabeth Hoffman, North America executive director (ED) at One - a campaign for financing and debt relief in poor countries, told the Financial Times:

“We are encouraged to hear that there is a waiver process for life-saving programmes, but remain concerned that this could get caught up in bureaucratic red tape.”

Effectively tackling HIV in sub-Saharan Africa

The need for far-reaching government-led efforts cannot be overemphasised as the signals from Trump are wake-up calls for Nigeria and Africa: now is the time to build pharmaceutical independence; it is time for the continent to take its health system seriously. For Nigeria, it cannot continue to depend on donations for its own healthcare.

Read also

"People will die": Medical expert sounds alarm over Trump’s HIV funding shutdown

Amid the uncertainty, Nigeria announced on Friday, January 31, 2025, that it is set to begin production of HIV/AIDS anti-retroviral drugs.

Speaking at a public event in Ilorin, Kwara state, in the northcentral region, Dr Temitope Ilori, the director-general (DG) of NACA, disclosed that plans are on to begin domestic production of HIV commodities before the end of 2025—a move that could see the end of overreliance on donor support. She explained that domestic production of HIV commodities such as test kits and anti-retroviral drugs was part of measures the government was taking to end AIDS as a public health threat by 2030.

In the same vein, experts urged President Bola Tinubu and members of his cabinet to get in touch with manufacturers of antiretroviral drugs quickly and provide the necessary funding to keep subsidising drugs amid the war against HIV/AIDS.

"The government should act quickly," a veteran Nigerian journalist Etim Etim reasoned during a guest appearance on Channels Television's 'Inside Sources'. "They (need to) get in touch with the manufacturers of those antiretroviral drugs, provide direct funding to the manufacturers and bring those drugs to this country."

Read also

Trump stops HIV funding for Nigeria, other developing countries, gives reason

Likewise, in a conversation, Stavros Nicolaou, group senior executive at Aspen Pharmacare, emphasised the need for technology transfer to strengthen Africa's pharmaceutical sector. Nicolaou highlighted how the COVID-19 pandemic exposed Africa's vulnerabilities, stressing the urgency of self-reliance, advanced planning, and local pandemic management.

Looking ahead, the pharmaceutical expert encouraged policy-makers and stakeholders to push for lasting reforms, ensuring Africa genuinely takes control of its healthcare future.

Top African countries receiving most US aid

Earlier, Legit.ng spotlighted the top five African countries that received the most US foreign aid in 2024.

Sub-Saharan Africa remains a significant recipient of US foreign aid, benefiting from various initiatives aimed at addressing health, food security, energy access, and economic development.

Proofreading by Nkem Ikeke, journalist and copy editor at Legit.ng.

PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy!

Source: Legit.ng

Authors:
Ridwan Adeola avatar

Ridwan Adeola (Current Affairs Editor) Ridwan Adeola Yusuf is a content creator with more than nine years of experience, He is also a Current Affairs Editor at Legit.ng. He holds a Higher National Diploma in Mass Communication from the Polytechnic Ibadan, Oyo State (2014). Ridwan previously worked at Africa Check, contributing to fact-checking research works within the organisation. He is an active member of the Academic Excellence Initiative (AEI). In March 2024, Ridwan completed the full Google News Initiative Lab workshop and his effort was recognised with a Certificate of Completion. Email: ridwan.adeola@corp.legit.ng.